Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial) M. Yoshida, K. Muro, A. Tsuji,

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Plantar Flexion as an Alternative to Treadmill Exercise for Evaluating Patients with Intermittent Claudication K. Yamamoto, T. Miyata, A. Onozuka, H. Koyama,

Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306) D.P. Modest, I. Ricard,

Breast Cancer Advocacy across Europe through the work and development of EUROPA DONNA, the European Breast Cancer Coalition M. Buchanan, S. Kyriakides,

Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell.

European Journal of Cancer

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST) Axel.

Rare cancers of the head and neck area in Europe

Volume 144, Issue 1, Pages (January 2017)

European Journal of Cancer

Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind.

First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)

Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without.

Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine Alice S. Forster, Jo Waller

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations.

Volume 195, Issue 5, Pages (May 2016)

Oncol Res Treat 2016;39: DOI: /

Association between 11 genetic polymorphisms in folate-metabolising genes and head and neck cancer risk Ana Lívia Silva Galbiatti, Lidia Maria Rebolho.

Volume 58, Issue 4, Pages (October 2010)

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Treatment decisions in metastatic colorectal cancer – Beyond first and second line combination therapies A. Vogel, R.D. Hofheinz, S. Kubicka, D. Arnold

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Volume 61, Issue 5, Pages (May 2012)

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Volume 53, Issue 5, Pages (May 2008)

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Volume 74, Issue 1, Pages (July 2018)

Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief Giovambattista Zeppetella, FRCP Journal.

Laurent Boccon-Gibod European Urology Supplements

Pain in cancer survivors; filling in the gaps

Aspirin in the prevention of cancer – Author's reply

Kaplan–Meier curves for a, b) progression-free survival (PFS) and c, d) overall survival (OS) in a, c) large-cell neuroendocrine carcinoma patients and.

Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.

Seizure - European Journal of Epilepsy

Type of anaesthesia and patient quality of recovery: a randomized trial comparing propofol–remifentanil total i.v. anaesthesia with desflurane anaesthesia

Adjuvant chemotherapy for rectal cancer – Authors' reply

Effect of combining tramadol and morphine in adult surgical patients: a systematic review and meta-analysis of randomized trials V. Martinez, L. Guichard,

Targeting T Cell Co-receptors for Cancer Therapy

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

ERCC1 and BRAC1 mRNA Expression Levels in the Primary Tumor Could Predict the Effectiveness of the Second-Line Cisplatin-Based Chemotherapy in Pretreated.

Phase I/II Study of Docetaxel/Cisplatin/Fluorouracil Combination Chemotherapy Against Metastatic Esophageal Squamous Cell Carcinoma Hiroaki Takahashi,

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

The 10-year cumulative incidence of CRC death or death due to other causes in patients treated with adjuvant chemotherapy after surgery for stages II–III.

An Updated Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated.

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Kaplan-Maier survival curves of 10-year DFS (A and B) and OS (C and D) according to PS 0 and PS≥1 in patients treated with adjuvant chemotherapy after.

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer David R. Spigel,

European Urology Oncology

Management of Prostate Cancer: Global Strategies

Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

New trials and results in systemic treatment of HCC

Risk of new or recurrent cancer after a high perioperative inspiratory oxygen fraction during abdominal surgery C.S. Meyhoff, L.N. Jorgensen, J. Wetterslev,

Table of contents The Journal for Nurse Practitioners

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J

Volume 67, Issue 4, Pages (April 2015)

J. Carlisle, M. Swart, E.J.C. Dawe, M. Chadwick

Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer:

Volume 54, Issue 1, Pages (July 2008)

Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study H Ismail,

Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Kaplan-Meier curves for PFS (panel A) and OS (panel B) of patients with mTCC receiving an anti-EGFR based therapy. mTCC, metastatic transverse colon cancer;

Fate of the contralateral leg after infrainguinal bypass

A Randomized, Phase II Trial of Two Dose Levels of Temsirolimus (CCI-779) in Patients with Extensive-Stage Small-Cell Lung Cancer Who Have Responding.

Presentation transcript:

Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial) M. Yoshida, K. Muro, A. Tsuji, Y. Hamamoto, T. Yoshino, K. Yoshida, K. Shirao, Y. Miyata, D. Takahari, T. Takahashi, A. Ohtsu European Journal of Cancer Volume 51, Issue 8, Pages 935-941 (May 2015) DOI: 10.1016/j.ejca.2015.03.007 Copyright © 2015 The Authors Terms and Conditions

Fig. 1 Progression-free survival. European Journal of Cancer 2015 51, 935-941DOI: (10.1016/j.ejca.2015.03.007) Copyright © 2015 The Authors Terms and Conditions

Fig. 2 Overall survival. European Journal of Cancer 2015 51, 935-941DOI: (10.1016/j.ejca.2015.03.007) Copyright © 2015 The Authors Terms and Conditions

Fig. 3 Overall survival (OS) according to risk group. European Journal of Cancer 2015 51, 935-941DOI: (10.1016/j.ejca.2015.03.007) Copyright © 2015 The Authors Terms and Conditions